. [82] to assess the efficacy, security and tolerability of Cannabidiol as an adjunct therapy together with anti-epileptic medicine around the individuals suffering from tuberous sclerosis intricate whose most popular neurological symptom is epilepsy. On this clinical demo examine, just after cure with Cannabidiol, responder price in the patients s